Geode Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,058,094
Closed -$6.45M 5033
2021
Q3
$6.45M Buy
1,058,094
+226,660
+27% +$1.38M ﹤0.01% 2763
2021
Q2
$6.84M Buy
831,434
+61,459
+8% +$506K ﹤0.01% 2723
2021
Q1
$6.89M Buy
769,975
+65,425
+9% +$586K ﹤0.01% 2614
2020
Q4
$8.13M Buy
704,550
+32,602
+5% +$376K ﹤0.01% 2301
2020
Q3
$6.99M Buy
671,948
+80,276
+14% +$836K ﹤0.01% 2186
2020
Q2
$7.78M Buy
591,672
+83,632
+16% +$1.1M ﹤0.01% 2082
2020
Q1
$4M Buy
508,040
+34,523
+7% +$272K ﹤0.01% 2267
2019
Q4
$9.8M Buy
473,517
+34,020
+8% +$704K ﹤0.01% 2018
2019
Q3
$6.02M Buy
439,497
+6,819
+2% +$93.5K ﹤0.01% 2273
2019
Q2
$5.32M Buy
432,678
+25,504
+6% +$314K ﹤0.01% 2344
2019
Q1
$5.08M Buy
407,174
+22,741
+6% +$284K ﹤0.01% 2328
2018
Q4
$4.35M Buy
384,433
+7,814
+2% +$88.4K ﹤0.01% 2303
2018
Q3
$7.05M Buy
376,619
+14,996
+4% +$281K ﹤0.01% 2149
2018
Q2
$9.35M Buy
361,623
+51,837
+17% +$1.34M ﹤0.01% 1920
2018
Q1
$6.94M Buy
309,786
+5,828
+2% +$131K ﹤0.01% 2029
2017
Q4
$7.61M Buy
303,958
+79,115
+35% +$1.98M ﹤0.01% 1937
2017
Q3
$5.44M Buy
224,843
+14,849
+7% +$359K ﹤0.01% 2152
2017
Q2
$4.25M Buy
209,994
+5,637
+3% +$114K ﹤0.01% 2266
2017
Q1
$5.5M Buy
204,357
+17,318
+9% +$466K ﹤0.01% 2033
2016
Q4
$3.56M Buy
187,039
+29,397
+19% +$559K ﹤0.01% 2271
2016
Q3
$3.08M Buy
157,642
+12,246
+8% +$239K ﹤0.01% 2283
2016
Q2
$2.18M Buy
145,396
+70,122
+93% +$1.05M ﹤0.01% 2418
2016
Q1
$692 Buy
75,274
+2,312
+3% +$21 ﹤0.01% 3071
2015
Q4
$1.41M Buy
72,962
+1,003
+1% +$19.3K ﹤0.01% 2704
2015
Q3
$1.07M Buy
71,959
+5,308
+8% +$78.9K ﹤0.01% 2831
2015
Q2
$1.46M Buy
66,651
+6,115
+10% +$134K ﹤0.01% 2690
2015
Q1
$1.36M Buy
60,536
+26,193
+76% +$590K ﹤0.01% 2692
2014
Q4
$693K Buy
34,343
+8,679
+34% +$175K ﹤0.01% 3025
2014
Q3
$468K Buy
25,664
+4,369
+21% +$79.7K ﹤0.01% 3199
2014
Q2
$287K Buy
21,295
+270
+1% +$3.64K ﹤0.01% 3393
2014
Q1
$345K Buy
+21,025
New +$345K ﹤0.01% 3306